Hims & Hers Health (HIMS) Cash from Operations (2019 - 2026)
Hims & Hers Health (HIMS) reported Cash from Operations of 89356000.0 for Q1 2026, down 18.09% on a YoY basis from 109090000.0 in Q1 2025, and up 45.74% sequentially from 61312000.0 in Q4 2025.
Hims & Hers Health (HIMS) Cash from Operations (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Cash from Operations data on file, last reported at 89356000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 18.09% year-over-year to 89356000.0; the trailing twelve-month figure through Mar 2026 stood at 280272000.0 (down 16.17% YoY), and the FY2025 full-year result was 300006000.0, up 19.48% from the prior year.
- Cash from Operations grew to 89356000.0 in Q1 2026, from 61312000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 148721000.0 in Q3 2025 to a low of 19403000.0 in Q1 2022.
- A 5-year average of 40435176.47 and a median of 25191000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 1163.89% in 2022 and soared 427.18% in 2023, its largest moves.
- Tracing HIMS's Cash from Operations over 5 years: stood at 6719000.0 in 2022, then soared by 427.18% to 21983000.0 in 2023, then soared by 292.96% to 86385000.0 in 2024, then decreased by 29.02% to 61312000.0 in 2025, then surged by 45.74% to 89356000.0 in 2026.
- Business Quant data shows HIMS's Cash from Operations at 89356000.0 in Q1 2026, 61312000.0 in Q4 2025, and 148721000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | 89.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.36 Mn |
| Mar 31, 2026 | 89.36 Mn |
| Dec 31, 2025 | 61.31 Mn |
| Dec 31, 2025 | 61.31 Mn |
| Sep 30, 2025 | 148.72 Mn |
| Sep 30, 2025 | 148.72 Mn |
| Jun 30, 2025 | -19.12 Mn |
| Jun 30, 2025 | -19.12 Mn |
| Mar 31, 2025 | 109.09 Mn |
| Mar 31, 2025 | 109.09 Mn |
| Dec 31, 2024 | 86.39 Mn |
| Dec 31, 2024 | 86.39 Mn |
| Sep 30, 2024 | 85.27 Mn |
| Sep 30, 2024 | 85.27 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Mar 31, 2024 | 25.84 Mn |
| Mar 31, 2024 | 25.84 Mn |
| Dec 31, 2023 | 21.98 Mn |
| Dec 31, 2023 | 21.98 Mn |